# Tailong Investment

> Tailong Investment is a VC fund backing Medical and Health Care. See 16 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 16
- Last investment: Jul 2026
- Lead investor: 50%
- Last updated: Aug 2026

Tailong Investment is an Investment firm.

## Contacts

5 contacts available for Tailong Investment. Shizune tracks 2 team members at Tailong Investment. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/tailong-investment?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 10 | 63% |
| Health Care | 8 | 50% |
| Biotechnology | 8 | 50% |
| Pharmaceutical | 5 | 31% |
| Medical Device | 4 | 25% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 8 | 50% |
| Series B | 4 | 25% |
| Seed | 2 | 13% |
| Angel | 1 | 6% |
| Series C | 1 | 6% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 10 | 63% |
| Switzerland | 1 | 6% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Sun Fa | Executive Director | 1 | https://shizune.co/investors/profile/sun-fa |
| Sun Jun | Executive Director | 1 | https://shizune.co/investors/profile/sun-jun-bd04 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Delova Biotech | Delova Biotech specializes in the field of pain treatment. It uses the company's rich R&D experience and special preparation technology platform to improve existing drugs and conduct research and development of improved new analgesics in China and the United States. | $88.6M | Series C | Jul 22, 2026 |  |
| Leman Biotech | Leman Biotech is a biotech company that is engaged in development of cancer immunotherapies. | $28.8M | Series A | Jan 26, 2026 |  |
| ROBO Medical | ROBO Medical is a medical robot research and development company. |  | Series B | Jul 18, 2025 |  |
| Imbioray | Imbioray is a biotechnology company that specializes in cellular immunotherapy for tumors and immune diseases. The company engages in the development of global CAR-NK and tiNK cell therapy drugs and is committed to solving the treatment of clinically unmet diseases. | $13.5M | Series A | Jan 21, 2025 |  |
| Mainstream Biotech | Mainstream Bio is a biotechnology company grounded in research, specializing in the development of innovative peptide therapeutics 2.0. |  | Series A | Jan 14, 2025 |  |
| Yili Pharmaceutical | Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development. | $100M | Angel | Dec 24, 2024 |  |
| Yili Pharmaceutical | Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development. | $13.7M | Seed | Dec 24, 2024 |  |
| C Ray Therapeutics | C Ray Therapeutics develops healthcare advancements through nuclear medicine. It was founded in 2020. | $100M | Series A | Nov 16, 2024 |  |
| XellSmart | Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China. | $14M | Series B | Oct 21, 2024 |  |
| BiyoPharma | BiyoPharma focuses on the research and development of innovative drugs for neurological diseases, including episodic and chronic migraines, through international technology platforms and improved treatment options. |  | Seed | Apr 26, 2024 |  |

10 of 16 investments shown.

## Co-investors
- [Taiyu Investment](https://shizune.co/investors/profile/taiyu-investment) — VC Fund, 4 deals together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 2 deals together
- [BOHE Angel Fund](https://shizune.co/investors/profile/bohe-angel-fund) — VC Fund, 2 deals together
- [Hangzhou Binjiang 5050 Fund](https://shizune.co/investors/profile/hangzhou-binjiang-5050-fund) — VC Fund, 2 deals together
- [Lula Capital](https://shizune.co/investors/profile/lula-capital) — VC Fund, 2 deals together
- [Oriza Holdings](https://shizune.co/investors/profile/oriza-holdings) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Tailong Investment invest in?

Tailong Investment invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 16 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Tailong Investment?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Tailong Investment?

The team at Tailong Investment includes Sun Fa (Executive Director) and Sun Jun (Executive Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co